文献速递主动脉疾病

全腔内主动脉弓治疗中原位开窗技术的短期结果

Short-Term Outcomes of In Situ Fenestration in Total Endovascular Aortic Arch Treatment.
PubMed 文献 · Ann Vasc Surg · 2021-11-12

单中心回顾性分析2017年6月至2019年10月21例累及主动脉弓的夹层或动脉瘤患者,采用原位开窗技术重建弓上分支,技术成功率95.2%,平均随访25.5±6.2个月无主动脉相关死亡或晚期内漏,桥接支架均通畅无移位。

要点

  • 原位开窗技术治疗累及主动脉弓的夹层或动脉瘤技术成功率95.2%。
  • 围术期并发症包括出血>1000ml 2例、卒中2例、心包积液1例、内漏3例。
  • 平均随访25.5±6.2个月无主动脉相关死亡及晚期内漏,桥接支架均通畅。

核心结论

  • 原位开窗技术并发症率和死亡率低,是全腔内主动脉弓修复的有效可行方法。
  • 需要长期随访研究评估其耐久性。

研究设计与样本

  • 回顾性单中心研究,纳入2017年6月至2019年10月接受原位开窗技术重建弓上分支的患者。
  • 共21例,其中A型主动脉夹层5例、B型主动脉夹层12例、胸主动脉瘤4例;男19例、女2例,平均年龄60.7±15.3岁。
  • 8例使用三开窗支架、1例使用双开窗支架、12例使用单开窗支架。

主要发现

  • 总体技术成功率95.2%。
  • 平均手术时间227.4±143.8分钟。
  • 并发症包括术中出血>1000ml 2例、卒中2例、心包积液1例、内漏3例(Ⅲ型2例、Ⅰ型1例)。
  • 平均随访25.5±6.2个月,无主动脉相关死亡或晚期内漏,桥接支架均通畅且无移位。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to analyze the short-term outcomes of in situ fenestration and discuss its feasibility and safety for the treatment of aortic dissection or aneurysm involving aortic arch. METHODS: A retrospective single-center review was conducted on patients who were treated with ISF technique to revascularize supra-arch branches from Jun 2017 to Oct 2019. Computed tomographic angiography was performed to assess the patency of bridging stents, endoleaks and prognosis prior to discharge, after 3 months, 6 months, 12 months and yearly thereafter. Patient demographics, operative details, clinical outcomes, and complications were analyzed and then discussed in this paper. RESULTS: A total of 21 patients were diagnosed with arch pathologies, 5 type A aortic dissections, 12 type B aortic dissections and 4 thoracic aortic aneurysms. There were 19 men and 2 women (mean age 60.7 ± 15.3). 8 cases were treated with three-fenestration stent grafts, 1 case with two-fenestration stent graft, and 12 cases with single-fenestration stent grafts. Overall technical success rate was 95.2%. Mean operation time was 227.4 ± 143.8 minutes. Complications were intraoperative hemorrhage (>1000 ml, 2), stroke (2), hydropericardium (1) and endoleaks (2 type Ⅲ, 1 type Ⅰ). There was no aorta-related mortality or late endoleaks during the mean follow-up of 25.5 ± 6.2 months. All the bridging stents remained patent and there was no migration according to follow-up Computed tomographic angiography. CONCLUSIONS: With low complication and mortality rate, ISF is an effective and feasible method for the total endovascular aortic arch repair. Long-term follow-up study is needed to evaluate its durability.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gao W, Yang G, Zhu Y, et al. Short-Term Outcomes of In Situ Fenestration in Total Endovascular Aortic Arch Treatment. Ann Vasc Surg. 2021. PMID: 34780960. doi:10.1016/j.avsg.2021.09.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。